Fang Ni - Jun 29, 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: Officer Title: Chief Business Officer and interim Chief Financial Officer
Signature: Brent Hatzis-Schoch, as Attorney-in-Fact
Stock symbol: BDTX
Transactions as of: Jun 29, 2022
Transactions value $: $61,018
Form type: 4
Date filed: 6/30/2022, 04:05 PM
Previous filing: Feb 17, 2022
Next filing: Dec 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Purchase	$61K	+25K	+56.78%	$2.44	69K	Jun 29, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.394 to $2.5599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.394 to $2.5599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Remarks:

Officer Title: Chief Business Officer and interim Chief Financial Officer